error
Kurzer Serviceunterbruch am Donnerstag, 19. Februar 2026, 12 bis 13 Uhr. Sie können in diesem Zeitraum keine neuen Dokumente hochladen oder bestehende Einträge bearbeiten. Das Login wird in diesem Zeitraum deaktiviert. Grund: Wartungsarbeiten // Short service interruption on Thursday, February 19, 2026, 12.00 – 13.00. During this time, you won’t be able to upload new documents or edit existing records. The login will be deactivated during this time. Reason: maintenance work
 

Cardiac remodeling in patients with centrifugal left ventricular assist devices assessed by serial echocardiography


Date

2022-05

Publication Type

Journal Article

ETH Bibliography

yes

Citations

Altmetric

Data

Abstract

Aim: The aim of the study was to characterize the remodeling process in a large cohort of patients supported with a centrifugal left ventricular assist device (cfLVAD) by standardized serial echocardiography. Methods and Results: From 3/2018 all cfLVAD patients underwent transthoracic echocardiography at 6 and 12 months after implantation using a standardized protocol. A total of 512 echocardiograms were reviewed (216 preoperative, 156 at 6 months, 140 at 12 months). While on cfLVAD support, left ventricular (LV) diameter decreased (p <.001). LV ejection fraction (LVEF) and LV fractional area change improved (p <.001). Potential for cfLVAD explantation (as defined by an LVEF ≥45% and opening of the aortic valve [AV]) was seen in nine patients at 6 and 21 patients at 12 months. The tricuspid annular excursion decreased significantly, while the right ventricular fractional area change did not change. Tricuspid regurgitation (TR) and mitral regurgitation (MR) improved significantly during LVAD support. Opening of the AV was seen in >64% of the patients at 6 months and in 66% at 12 months. Moderate aortic regurgitation (AR) was rare with 3.8% at 6 months but increased with the duration of cfLVAD support (8.5% at 12 months). We found no significant difference in echocardiographic parameters between patients supported with a HeartWare HVAD™ or a HeartMate 3™ device. Conclusion: LVAD therapy can lead to reverse LV remodeling and improvement of MR and TR. However, right ventricular function does not improve and prevalence of AR progressively increases during mechanical support.

Publication status

published

Editor

Book title

Journal / series

Echocardiography

Volume

39 (5)

Pages / Article No.

667 - 677

Publisher

BMJ

Event

Edition / version

Methods

Software

Geographic location

Date collected

Date created

Subject

echocardiography; LVAD; left ventricular assist device

Organisational unit

09667 - Falk, Volkmar (ehemalig) / Falk, Volkmar (former) check_circle

Notes

Funding

Related publications and datasets